Group A rotaviruses are a major cause of severe gastroenteritis in children
under 4 y of age worldwide. Group A rotaviruses have been identified in ma
ny animal and bird species, they are antigenically complex, and multiple se
rotypes infect humans. Re-assortant rotavirus vaccines are now available wh
ich confer protection against severe illness due to rotavirus serotypes G1-
4. Before vaccines are introduced it is necessary to establish the diversit
y of rotavirus in the target population to ensure efficacy and to establish
a baseline for future surveillance strategies. The purpose of this review
is to describe our current knowledge of the diversity of rotaviruses across
Europe. Since multinational studies with standardized methodology have not
been performed, this review is based on the available published studies. I
n Europe, more than 90% of Group A rotavirus strains that have been typed a
re of serotypes G1-4, with an average 8% of non-G1-4 strains in published s
tudies. The percentage of non-typeable strains may fluctuate from one year
to another, and has been as high as 18% in one study in Great Britain, indi
cating the need for a more systematic study. Group A rotavirus infection ty
pically occurs as a winter peak in the European countries studied. Comparis
on of seasonality data from national laboratory surveillance systems showed
seasonal differences, with the annual rotavirus peak occurring first in Sp
ain, usually in December, followed by France in February, and ending in Nor
thern Europe in England and Wales in February or March, and the Netherlands
and Finland in March.